Metropolis Healthcare Limited (NSE: METROPOLIS)

Market Cap	105.71B
Revenue (ttm)	12.85B
Net Income (ttm)	1.48B
Shares Out	51.27M
EPS (ttm)	28.77
PE Ratio	71.66
Forward PE	52.27
Dividend	4.00 (0.19%)
Ex-Dividend Date	n/a

Volume	106,266
Open	2,010.00
Previous Close	2,015.75
Day's Range	2,009.95 - 2,071.40
52-Week Range	1,450.00 - 2,318.30
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laborat...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 4,313
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: METROPOLIS

Financial Performance

In 2023, Metropolis Healthcare's revenue was 12.08 billion, an increase of 5.18% compared to the previous year's 11.48 billion. Earnings were 1.28 billion, a decrease of -10.54%.